1. Home
  2. BNZI vs CLGN Comparison

BNZI vs CLGN Comparison

Compare BNZI & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.07

Market Cap

15.7M

Sector

N/A

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.62

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
CLGN
Founded
2016
2004
Country
United States
Israel
Employees
28
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
18.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
BNZI
CLGN
Price
$1.07
$0.62
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$23.00
$11.00
AVG Volume (30 Days)
565.8K
33.0K
Earning Date
05-14-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$185.61
$1,596.12
Revenue Next Year
$32.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.50
52 Week High
$4.44
$4.98

Technical Indicators

Market Signals
Indicator
BNZI
CLGN
Relative Strength Index (RSI) 47.84 43.97
Support Level $0.92 $0.58
Resistance Level $1.12 $0.73
Average True Range (ATR) 0.07 0.08
MACD 0.00 0.03
Stochastic Oscillator 79.05 24.26

Price Performance

Historical Comparison
BNZI
CLGN

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: